Cargando…
Pharmacokinetic Evaluation of a DSPE-PEG(2000) Micellar Formulation of Ridaforolimus in Rat
The rapamycin analog, ridaforolimus, has demonstrated potent anti-proliferative effects in cancer treatment, and it currently is being evaluated in a range of clinical cancer studies. Ridaforolimus is an extremely lipophilic compound with limited aqueous solubility, which may benefit from formulatio...
Autores principales: | Remsberg, Connie M., Zhao, Yunqi, Takemoto, Jody K., Bertram, Rebecca M., Davies, Neal M., Forrest, Marcus Laird |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834941/ https://www.ncbi.nlm.nih.gov/pubmed/24300398 http://dx.doi.org/10.3390/pharmaceutics5010081 |
Ejemplares similares
-
Ridaforolimus
Publicado: (2012) -
DSPE-PEG Modification of α-Conotoxin TxID
por: Zhao, Weinan, et al.
Publicado: (2019) -
Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
por: Huang, Xiaolong, et al.
Publicado: (2017) -
Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells
por: HU, JUN, et al.
Publicado: (2016) -
Effects of mPEG-DSPE/corannulene or perylene nanoparticles on the ovary and oocyte
por: Wang, Hongyu, et al.
Publicado: (2020)